Sanofi and Regeneron acknowledged that testing their ... quality of life and respiratory symptom scores in what looks like a comprehensive win for the antibody. Already raking in $9 billion ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era. But even as the billions pile up, Regeneron isn't entirely happy with ...